Mary Miller - Apr 17, 2025 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Chief Legal Officer
Signature
/s/ Adam D. Levy, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Apr 17, 2025
Transactions value $
-$1,010
Form type
4
Date filed
4/18/2025, 03:51 PM
Previous filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability -$1.01K -558 -1.51% $1.81 36.5K Apr 17, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.